Your browser doesn't support javascript.
loading
Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo.
Yu, Ko-Hua; Kuo, Chan-Yen; Wu, I-Ting; Chi, Ching-Ho; Tsai, Keng-Chang; Kuo, Ping-Chung; Zeng, Jing-Wen; Hung, Chin-Chuan; Hung, Hsin-Yi.
Afiliación
  • Yu KH; School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan.
  • Kuo CY; Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan.
  • Wu IT; Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, 406, Taiwan.
  • Chi CH; School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan.
  • Tsai KC; Ministry of Health and Welfare, National Research Institute of Chinese Medicine, Taipei, 112, Taiwan.
  • Kuo PC; School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan.
  • Zeng JW; School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan.
  • Hung CC; Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, 406, Taiwan; Department of Pharmacy, China Medical University Hospital, Taichung, 404, Taiwan; Department of Healthcare Administration, Asia University, Taichung, 500, Taiwan. Electronic address: cchung@mail.cmu.edu.tw.
  • Hung HY; School of Pharmacy, College of Medicine, National Cheng Kung University, Tainan, 701, Taiwan. Electronic address: z10308005@email.ncku.edu.tw.
Eur J Pharmacol ; 960: 176146, 2023 Dec 05.
Article en En | MEDLINE | ID: mdl-37884184

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Eur J Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Eur J Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Taiwán